Your browser doesn't support javascript.
loading
Is bone marrow biopsy always indicated in patients with primary cutaneous marginal zone B-cell lymphoma?
Muniesa, C; Hernández-Machín, B.
Affiliation
  • Muniesa C; Servicio de Dermatología, Hospital de Viladecans, Barcelona, Spain. Electronic address: cristinamuniesa@hotmail.com.
Actas Dermosifiliogr ; 104(8): 667-71, 2013 Oct.
Article in En | MEDLINE | ID: mdl-23954046
ABSTRACT
Bone marrow involvement at the time of diagnosis is uncommon in patients with primary cutaneous marginal zone B-cell lymphoma (PCMZL). Moreover, in these patients such involvement is rarely found in isolation on diagnosis. Typically the few patients with PCMZL who have early bone marrow involvement also present secondary nodal or visceral involvement, which is detected by other staging studies (usually computed tomography). In recent years, this has given rise to some debate about whether a bone marrow biopsy should be routinely performed in patients diagnosed with PCMZL in view of the good prognosis and low incidence of bone marrow infiltration and/or extracutaneous involvement in this type of lymphoma.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Bone Marrow / Bone Marrow Examination / Lymphoma, B-Cell, Marginal Zone / Unnecessary Procedures Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Actas Dermosifiliogr Year: 2013 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Bone Marrow / Bone Marrow Examination / Lymphoma, B-Cell, Marginal Zone / Unnecessary Procedures Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Actas Dermosifiliogr Year: 2013 Document type: Article